🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting news for CBDI! Cincinnati Children’s is developing an Applied Gene and Cell Therapy Center, which will increase clinical trials of innovative drugs and biological therapeutics for patients with cancer, blood diseases or genetic disorders: scienceblog.cincinnatichildrens.org/60m-applied-ge…

It was a super exciting to be on the podcast “talk python to me” and discuss how python is used in genomics, molecular pathology, and patient care!! Thank you Michael Kennedy for having me on your show. Anil Parwani Liron Pantanowitz Association for Molecular Pathology Alexis Carter, MD youtube.com/watch?v=L6AAOm…

#AMPEurope started today with a bang!!! Great talks on implementation of #newbornsequencing, identification of disease causing rearrangements in #noncodingrna, #artificialintelligence #genetics and #pathology Association for Molecular Pathology #molecularpathology #moleculardiagnostics

New preprint from katherlab: large language models for end-to-end clincial trial matching. Our system parses study protocols and patient records, and matches them. We evaluate thoroughly against human experts and find >90% correspondence. Led by Dyke Ferber 🤩

Pangene now published in Bioinformatics: doi.org/10.1093/bioinf…. In addition to showcasing applications (see the 17q21.31 inversion below), we also reviewed the theoretical formulation of bidirected graphs and discussed the definition and the finding of "bubbles" in such graphs.

#SickleCell therapy developed Cincinnati Children's CincyChildren's CBDI shows long-term safety in mice. Data supported launch of phase 1/2 first-in-human clinical trial in the U.S. Congrats to Dr. Malik and colleagues! #stemcell #genetherapy Findings PLOS One ncbi.nlm.nih.gov/pmc/articles/P…

Thank you Association for Molecular Pathology!!

We are honored to be the #1 Cancer Program in the Nation again. To our staff, thank you for your tremendous work for our patients, and for supporting one another. To our patients and families, thank you for trusting us with your care. 🎗️

Molecular testing is a busy area under construction for the guidelines group! #2024ATA #AmericanThyroidAssociation Julie A Sosa, MD American Thyroid Association

Kicking off the malignant histiocytosis education session with Dr. Jennifer Picarsic! #HSGoa2024 #histiocytosis #malignancy

At today's meeting of the Association for Molecular Pathology board of directors, we thanked the 2024 board for its service and welcomed the 2025 board. It's volunteers like these who make all that we do possible!

Jonathan A. Nowak kicking off the amazing #AMPath24! Association for Molecular Pathology

Jonathan Nowak started off the #AMPath24 Association for Molecular Pathology Annual meeting!

Happening now: #AMPath24 celebrates the contributions of Atul Butte.

Maria Arcila is doing a stellar job presenting the history of AMP - stay tuned to see the article in this in ⁦The Journal of Molecular Diagnostics -⁩ #AMPath24 Association for Molecular Pathology

It was an honor to share the stage with Birgit Funke to talk about the value of #insilicomutagenesis for clinical NGS tests!! Thank you Lisa Kalman and Association for Molecular Pathology for the opportunity to share our work.

What a thrill it was last month to win both the American College of Medical informatics ACMI Morris F. Collen Award of Excellence (amia.org/communities/ac…) and the Association for Molecular Pathology Association for Molecular Pathology Award for Excellence in Molecular Diagnostics (amp.org/membership/awa…)!

Molecular testing in lung cancer explained in ONE POWERPOINT SLIDE!! Link: youtu.be/KrgPeGrHaR8?si…

Nice to see the impact of this important work. This benchmark set (v4.2.1) drove a huge amount of improvement sequencing. All seq instruments use it to quantify performance. Best credit is to Genome in a Bottle, who drove the field forward both in this work and over a decade.

#LegacyContent: Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms. From Association for Molecular Pathology member Dr. Arcila and colleagues from Memorial Sloan Kettering Cancer Center and Invivoscribe jmdjournal.org/article/S1525-…